Answers are grounded in this paper and cite their sources.
This review highlights diagnostic challenges and resistance in cerebral aspergillosis, indicating effective antifungal treatment is crucial to improve mortality rates.
Cerebral aspergillosis is a well-recognized and particularly severe manifestation of invasive aspergillosis, primarily affecting immunocompromised individuals. The condition is associated with high morbidity and mortality, largely due to diagnostic challenges and limited treatment options. This review examines the epidemiology, risk factors, and diagnostic issues before focusing on drug treatment, including the pharmacokinetics and pharmacodynamics of antifungal agents in the central nervous system. Resistance to current antifungal therapies is also discussed, along with future research directions.
No takes yet. Share an insight, caveat, or question.
Chantelot et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: